NLRP3 and metabolic dysfunction-associated steatohepatitis: Glycyrrhizin and its metabolites glycyrrhetinic acid can attenuate non-alcoholic steatohepatitis-induced liver fibrosis, which is mediated by suppression of NLR family pyrin domain-containing 3 (NLRP3) inflammasome and restoration of bile acid homeostasis (153).